FAAM EUROBAT 2024

Back
21 - 23 November 2024 Athens, Greece

TPS1 - Poster Session 1

Thursday 21 Nov, 14:30 PM - 15:30 PM Athens, Greece
Ypsilon & Omikron Poster Session
Abstract Text
14:30 Day1-28
A 2-year-old boy with an unusual history of sever nut allergy: a case report
Abstract Text
14:30 Day1-40
A lineblot-based feasibility study to elucidate allergy sensitization patterns
Abstract Text
14:30 Day1-31
ALLERGY TO TOMATOES AND MUSTARD IN A PATIENT WITH MULTIPLE IgE SENSITISATIONS TO FOOD LIPID TRANSFER PROTEINS
Abstract Text
14:30 Day1-24
Assessing the Clinical Performance of a Basophil Activation Test for Allergic Disorders under IVDR Compliance
Abstract Text
14:30 Day1-18
Case Report: Biphasic anaphylaxis in a 4-Month-Old Infant with Cow's Milk Allergy
Abstract Text
14:30 Day1-20
Characterisation of allergic reactions in Swiss children with food allergies
Abstract Text
14:30 Day1-34
Clinical features of patients diagnosed with alpha- gal syndrome referred to an allergy clinic in Sri Lanka
Abstract Text
14:30 Day1-23
Eosinophilic Esophagitis and allergic comorbidities
Abstract Text
14:30 Day1-41
Eosinophilic esophagitis related to pollen-containing apitherapy and herbal products with Asteraceae flowers: a case report
Abstract Text
14:30 Day1-45
Feasibility of a Streamlined, Miniaturized and Multi-Allergen Approach to Basophil Activation Test
Abstract Text
14:30 Day1-25
Features of food sensitization and food allergy in patients with severe genodermatosis
Abstract Text
14:30 Day1-19
Fostering community eases navigating food allergy distress: Findings from French caregivers in the GAPS study
Abstract Text
14:30 Day1-38
Gibberellin-Regulated Protein Allergy with Negative Peach Extract: a case series
Abstract Text
14:30 Day1-39
Heated milk tolerance in Finnish cow’s milk allergic children
Abstract Text
14:30 Day1-32
IgE reactivity profile to respiratory and food allergen components among patients with allergic rhinitis with and without asthma
Abstract Text
14:30 Day1-37
Impact of molecular allergy tests on diagnosis and treatment of eosinophilic esophagitis
Abstract Text
14:30 Day1-27
MOLECULAR IgE SENSITIZATION PROFILE IN A PATIENT WITH ADULT ATOPIC DERMATITIS AND CHRONIC URTICARIA SYNDROME TO FOODS
Abstract Text
14:30 Day1-44
Monitoring of the direct impact of respiratory diseases of local residents due to exposure distance of complex industrial air pollution
Abstract Text
14:30 Day1-33
Mycoprotein allergy and sensitisation to mould aeroallergens: a case-control study
Abstract Text
14:30 Day1-16
PR-10 Protein-Induced Anaphylaxis in a Birch-Free Region: Case Reports from Mediterranean Spain Highlighting Environmental and Hormonal Cofactors
Abstract Text
14:30 Day1-30
Peanut and tree nut allergy screening by Basophil Activation Testing
Abstract Text
14:30 Day1-17
Peanut oral immunotherapy has not recuded basophil activation
Abstract Text
14:30 Day1-21
Prioritization of children with anaphylaxis at Pediatric Emergency Departments in Spain: Results of a National Survey
Abstract Text
14:30 Day1-22
Safety and effectiveness of Jorveza® in 9 children with eosinophilic esophagitis (EoE)
Abstract Text
14:30 Day1-26
Selective allergy to goat and sheep milk in cow milk-tolerant patients in Gipuzkoa, Basque Country, Spain: a case series
Abstract Text
14:30 Day1-42
Sensitisation testing in legume allergy: Is there correlation between serum specific IgE and skin prick test?
Abstract Text
14:30 Day1-29
Sesame allergy severity prediction in children: the role of skin prick-to-prick test

Chairs

Speakers